Colorectal Cancer Clinical Trials in High Point, NC

Colorectal Cancer Clinical Trials in High Point, NC

View the best 10 colorectal cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Colorectal Cancer clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for colorectal cancer in High Point, North Carolina

Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of sotorasib combined with panitumumab in patients with a specific type of colorectal cancer that has not responded to other treatments. Sotorasib targets a genetic mutation in the cancer cells, while panitumumab helps the immune system attack the cancer. The goal is to see if this combination can help patients live longer without their cancer getting worse.
Image of South Texas Accelerated Research Therapeutics in San Antonio, United States.

SGN-MesoC2

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is looking at a new drug called SGN-MesoC2 for treating advanced solid tumors, which are cancers that have grown in one place or spread to other parts of the body. Patients
Image of Wake Forest School of Medicine in Winston-Salem, United States.

Choice PRO vs Fixed PRO

Recruiting1 award11 criteria
This trial is testing if letting people choose which health questionnaire to fill out leads to more people filling it out and if they find it more acceptable.
Image of Community Health Network in Indianapolis, United States.

LY3537982

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called LY3537982 in cancer patients with the KRAS G12C mutation. It targets this mutation to stop cancer cells from growing. The study includes patients who haven't responded to other treatments or cannot tolerate them. LY3537982 is a new drug targeting the KRAS G12C mutation, similar to previously approved drugs like sotorasib and adagrasib.
Image of Phoenix VA Health Care System, Phoenix, AZ in Phoenix, United States.

FIT +1 More

Procedure

Recruiting1 award
This trial compares two methods for colorectal cancer screening in people aged 50-75. One method uses a camera to find and remove precancerous growths, while the other checks for hidden blood in stool. The study aims to see which method better reduces cancer deaths over time.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Image of Site 1030 South Texas Accelerated Research Therapeutics (START) Midwest in Grand Rapids, United States.

BDTX-4933

Recruiting1 awardPhase 1
This trial studies a new oral medicine to treat certain advanced and metastatic cancers in adults. It looks at how safe and effective the medicine is.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Image of Sarah Cannon Research Institute - CO in Denver, United States.

ST316

WNT/β-catenin signaling pathway inhibitor

Recruiting1 awardPhase 1
This trial tests a new cancer drug to find if it's safe, how it works, and if it's effective against advanced solid tumors.
Image of Cancer Specialists of North Florida in Jacksonville, United States.

Sotorasib +1 More

Targeted Therapy

Recruiting2 awardsPhase 3
"This trial aims to see if a new treatment called sotorasib, along with panitumumab and FOLFIRI, can improve the time before the cancer progresses in patients with metast

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.